| scholarly article | Q13442814 |
| P50 | author | Timothy Bishop | Q29642370 |
| Nelleke A Gruis | Q42392971 | ||
| Brigitte Bressac-de Paillerets | Q43376253 | ||
| Derek Nancarrow | Q47538875 | ||
| Julia A Newton Bishop | Q47973102 | ||
| Florence Demenais | Q56420237 | ||
| Graham J Mann | Q56420238 | ||
| Margaret A. Tucker | Q87001219 | ||
| Paola Ghiorzo | Q88798374 | ||
| Alisa M. Goldstein | Q91400899 | ||
| Mark Harland | Q114374689 | ||
| Agnès Chompret | Q114374734 | ||
| P2093 | author name string | Johan Hansson | |
| Elizabeth A Holland | |||
| Michela Mantelli | |||
| Wilma Bergman | |||
| Nicholas Hayward | |||
| Anton Platz | |||
| Melanoma Genetics Consortium | |||
| P433 | issue | 12 | |
| P407 | language of work or name | English | Q1860 |
| P304 | page(s) | 894-903 | |
| P577 | publication date | 2002-06-01 | |
| P1433 | published in | Journal of the National Cancer Institute | Q400279 |
| P1476 | title | Geographical variation in the penetrance of CDKN2A mutations for melanoma | |
| P478 | volume | 94 |
| Q36808635 | A comparison of CDKN2A mutation detection within the Melanoma Genetics Consortium (GenoMEL). |
| Q48825624 | A genome-wide association study identifies novel single nucleotide polymorphisms associated with dermal shank pigmentation in chickens |
| Q36103193 | A germline mutation of CDKN2A and a novel RPLP1-C19MC fusion detected in a rare melanotic neuroectodermal tumor of infancy: a case report |
| Q52857972 | A mutation hotspot at the p14ARF splice site. |
| Q47566344 | A novel educational intervention targeting melanoma risk and prevention knowledge among children with a familial risk for melanoma |
| Q38267932 | A practice guideline from the American College of Medical Genetics and Genomics and the National Society of Genetic Counselors: referral indications for cancer predisposition assessment. |
| Q51686167 | A short acidic motif in ARF guards against mitochondrial dysfunction and melanoma susceptibility. |
| Q36993925 | A systematic review of interventions to improve adherence to melanoma preventive behaviors for individuals at elevated risk |
| Q44347453 | Absence of exon 15 BRAF germline mutations in familial melanoma |
| Q36843805 | Absence of germline CDKN2A mutation in Sicilian patients with familial malignant melanoma: Could it be a population-specific genetic signature? |
| Q40606325 | Activating BRAF and N-Ras mutations in sporadic primary melanomas: an inverse association with allelic loss on chromosome 9. |
| Q38093037 | Aetiology, genetics and prevention of secondary neoplasms in adult cancer survivors |
| Q36984855 | Altered transcriptome signature of phenotypically normal skin fibroblasts heterozygous for CDKN2A in familial melanoma: relevance to early intervention |
| Q38705693 | An interstitial deletion within 9p21.3 and extending beyond CDKN2A predisposes to melanoma, neural system tumours and possible haematological malignancies. |
| Q48437277 | Anticipated uptake of genetic testing for familial melanoma in an Australian sample: An exploratory study |
| Q37004702 | Anticipating dissemination of cancer genomics in public health: a theoretical approach to psychosocial and behavioral challenges |
| Q46409357 | Are 25 SNPs from the CARDIoGRAM study associated with ischaemic stroke? |
| Q92776817 | Assessing a single SNP located at TERT/CLPTM1L multi-cancer risk region as a genetic modifier for risk of pancreatic cancer and melanoma in Dutch CDKN2A mutation carriers |
| Q34212766 | Association of MC1R variants and host phenotypes with melanoma risk in CDKN2A mutation carriers: a GenoMEL study |
| Q36072486 | Associations between environmental factors and incidence of cutaneous melanoma. Review |
| Q57744383 | BRCA1, BRCA2, TP53, and CDKN2A germline mutations in patients with breast cancer and cutaneous melanoma |
| Q64981988 | Barriers to risk-understanding and risk-reduction behaviors among individuals with a family history of melanoma. |
| Q57314787 | Better the Devil You Know? High-Risk Individuals’ Anticipated Psychological Responses to Genetic Testing for Melanoma Susceptibility |
| Q90426524 | CDKN2A Germline Rare Coding Variants and Risk of Pancreatic Cancer in Minority Populations |
| Q79079264 | CDKN2A as a uveal and cutaneous melanoma susceptibility gene |
| Q52655109 | CDKN2A founder mutation in pancreatic ductal adenocarcinoma patients without cutaneous features of Familial Atypical Multiple Mole Melanoma (FAMMM) syndrome. |
| Q54739221 | CDKN2A mutations in melanoma families from Uruguay. |
| Q92353536 | CDKN2A testing and genetic counseling promote reductions in objectively measured sun exposure one year later |
| Q39012719 | CDKN2A unclassified variants in familial malignant melanoma: combining functional and computational approaches for their assessment. |
| Q51162850 | Cancer Susceptibility Gene Mutations in Individuals With Colorectal Cancer. |
| Q34992880 | Cancer risk assessment for the primary care physician |
| Q28238393 | Capturing the biological impact of CDKN2A and MC1R genes as an early predisposing event in melanoma and non melanoma skin cancer |
| Q42736022 | Case report of a KIT-mutated melanoma patient with an excellent response to apatinib and temozolomide combination therapy |
| Q50549151 | Characteristics of the coexistence of melanoma and renal cell carcinoma. |
| Q31104539 | Chemoprevention of melanoma |
| Q38197938 | Clinical applications of melanoma genetics. |
| Q80411898 | Clinical characteristics of familial vs. sporadic non-Hodgkin lymphoma in patients diagnosed at the Mayo Clinic (1986-2000) |
| Q35761693 | Clinical germline genetic testing for melanoma. |
| Q40249638 | Coexistence of amelanotic melanoma and liposarcoma |
| Q39160326 | Combined p19Arf and interferon-beta gene transfer enhances cell death of B16 melanoma in vitro and in vivo |
| Q36930013 | Comprehensive analysis of CDKN2A (p16INK4A/p14ARF) and CDKN2B genes in 53 melanoma index cases considered to be at heightened risk of melanoma |
| Q47153881 | Constitutional mutation in CDKN2A is associated with long term survivorship in multiple myeloma: a case report |
| Q35077763 | Constitutive mitochondrial DNA copy number in peripheral blood of melanoma families with and without CDKN2A mutations |
| Q36049052 | Cutaneous melanoma |
| Q36365453 | Cutaneous melanoma: family screening and genetic testing |
| Q30312252 | Cutaneous melanoma: hints from occupational risks by anatomic site in Swedish men. |
| Q37352015 | Cutaneous melanoma: how does ultraviolet light contribute to melanocyte transformation? |
| Q36567113 | Cutaneous melanomas of the eyelid |
| Q56893570 | Cutaneous phenotype andMC1R variants as modifying factors for the development of melanoma inCDKN2A G101W mutation carriers from 4 countries |
| Q42415481 | Deletion at chromosome arm 9p in relation to BRAF/NRAS mutations and prognostic significance for primary melanoma |
| Q36409368 | Detection of Exosomal miRNAs in the Plasma of Melanoma Patients |
| Q35112869 | Effectiveness and causes for failure of surveillance of CDKN2A-mutated melanoma families. |
| Q48092515 | Emerging Biomarkers in Cutaneous Melanoma. |
| Q38118359 | Emerging trends in the epidemiology of melanoma |
| Q64975143 | Epidemiological and genetic factors underlying melanoma development in Italy. |
| Q34162764 | Estimating CDKN2A carrier probability and personalizing cancer risk assessments in hereditary melanoma using MelaPRO. |
| Q88461678 | Evaluation of Biodistribution of Sulforaphane after Administration of Oral Broccoli Sprout Extract in Melanoma Patients with Multiple Atypical Nevi |
| Q52731993 | Extracting Fitness Relationships and Oncogenic Patterns among Driver Genes in Cancer. |
| Q61804952 | Familial Melanoma: Diagnostic and Management Implications |
| Q89884126 | Familial Pancreatic Cancer: Current Perspectives |
| Q28391589 | Familial malignant melanoma - overview |
| Q36674934 | Familial melanoma-associated mutations in p16 uncouple its tumor-suppressor functions |
| Q35566206 | Familial melanoma: a complex disorder leading to controversy on DNA testing. |
| Q30884218 | Familial risk of cancer: data for clinical counseling and cancer genetics |
| Q64983501 | Familial risk of melanoma and links with other cancers. |
| Q45230424 | Family history and the risk of cancer: genetic factors influencing multiple cancer sites |
| Q34979733 | Focus on melanoma |
| Q86517099 | Framing recommendations to promote prevention behaviors among people at high risk: A simulation study of responses to melanoma genetic test reporting |
| Q30375327 | Functional, structural, and genetic evaluation of 20 CDKN2A germ line mutations identified in melanoma-prone families or patients. |
| Q34515007 | Future perspectives in melanoma research: meeting report from the "Melanoma Bridge", Napoli, December 5th-8th 2013. |
| Q37004685 | Gene expression profiling and clinical outcome in melanoma: in search of novel prognostic factors |
| Q39672404 | Gene therapy for advanced melanoma: selective targeting and therapeutic nucleic acids. |
| Q37137000 | Genetic Determinants of Cutaneous Melanoma Predisposition |
| Q48212957 | Genetic Test Reporting and Counseling for Melanoma Risk in Minors May Improve Sun Protection Without Inducing Distress. |
| Q36314787 | Genetic counseling in melanoma. |
| Q35162369 | Genetic epidemiology of melanoma |
| Q33997130 | Genetic predisposition in cutaneous melanoma |
| Q37544403 | Genetic risk factors for melanoma |
| Q36055213 | Genetic test reporting enhances understanding of risk information and acceptance of prevention recommendations compared to family history-based counseling alone |
| Q49551579 | Genetic test reporting of CDKN2A provides informational and motivational benefits for managing melanoma risk |
| Q48523594 | Genetic testing for hereditary melanoma and pancreatic cancer: a longitudinal study of psychological outcome |
| Q46735021 | Genetic testing for melanoma risk: a prospective cohort study of uptake and outcomes among Australian families |
| Q34158316 | Genetic testing for melanoma. |
| Q48332903 | Genetic testing in familial melanoma: uptake and implications. |
| Q36563659 | Genetics of melanoma |
| Q34203435 | Genetics of melanoma predisposition |
| Q36216850 | Genetics of primary intraocular tumors |
| Q45194373 | Genital and anorectal mucosal melanoma is associated with cutaneous melanoma in patients and in families |
| Q84913701 | Genome-wide linkage analysis of Swedish families to identify putative susceptibility loci for cutaneous malignant melanoma |
| Q57948414 | Genome-wide linkage scan for atypical nevi in p16-Leiden melanoma families |
| Q57314586 | Genome-wide search for nevus density shows linkage to two melanoma loci on chromosome 9 and identifies a new QTL on 5q31 in an adult twin cohort |
| Q37005057 | Genomic Profiling of Thyroid Cancer Reveals a Role for Thyroglobulin in Metastasis |
| Q40595725 | Genomic alterations in spontaneous and carcinogen-induced murine melanoma cell lines |
| Q33431893 | Genomic imprinting and environment in hereditary paraganglioma |
| Q40707151 | Germline CDKN2A Mutation Status and Survival in Familial Melanoma Cases |
| Q35680356 | Global perspectives of contemporary epidemiological trends of cutaneous malignant melanoma |
| Q30470596 | Hereditary Genodermatoses with Cancer Predisposition |
| Q36599686 | Hereditary melanoma: Update on syndromes and management: Genetics of familial atypical multiple mole melanoma syndrome |
| Q33851085 | Hereditary pancreatic cancer: related syndromes and clinical perspective |
| Q57250703 | Heterogeneity of risk for melanoma and pancreatic and digestive malignancies |
| Q37152975 | Heterogeneous distribution of BRAF/NRAS mutations among Italian patients with advanced melanoma |
| Q36147888 | High prevalence of germline CDKN2A mutations in Slovenian cutaneous malignant melanoma families |
| Q28242124 | High risk of tobacco-related cancers in CDKN2A mutation-positive melanoma families |
| Q47774844 | High- and average-risk individuals' beliefs about, and perceptions of, malignant melanoma: an Australian perspective |
| Q39938055 | Identification of candidate tumor suppressor genes inactivated by promoter methylation in melanoma |
| Q37399647 | Identification of modifier genes for cutaneous malignant melanoma in melanoma-prone families with and without CDKN2A mutations |
| Q36055045 | Impact of melanoma genetic test reporting on perceived control over melanoma prevention |
| Q47270996 | Improvement of Genetic Testing for Cutaneous Melanoma in Countries With Low to Moderate Incidence: The Rule of 2 vs the Rule of 3. |
| Q56893626 | Influence of Genes, Nevi, and Sun Sensitivity on Melanoma Risk in a Family Sample Unselected by Family History and in Melanoma-Prone Families |
| Q42965794 | Interaction of CDKN2A and sun exposure in the etiology of melanoma in the general population |
| Q53130385 | LINE-1 methylation in peripheral blood and the risk of melanoma in melanoma-prone families with and without CDKN2A mutations. |
| Q56828381 | Lentigos, Melanocytic Naevi and Melanoma |
| Q33905176 | Localization of a novel melanoma susceptibility locus to 1p22 |
| Q36930086 | MELPREDICT: a logistic regression model to estimate CDKN2A carrier probability |
| Q21245465 | Main roads to melanoma |
| Q57664796 | Malignant Melanoma–a Genetic Overview |
| Q36695641 | Management of familial melanoma |
| Q37491030 | Management of malignant melanoma: best practices |
| Q37328311 | Management of melanoma families |
| Q38646092 | Melanoma Epidemiology and Prevention |
| Q35602637 | Melanoma epidemiology |
| Q35146540 | Melanoma etiology: where are we? |
| Q37334503 | Melanoma genetic counseling and test reporting improve screening adherence among unaffected carriers 2 years later |
| Q33726956 | Melanoma genetics and the development of rational therapeutics |
| Q56435948 | Melanoma risk for CDKN2A mutation carriers who are relatives of population-based case carriers in Australia and the UK |
| Q26783118 | Melanoma risk perception and prevention behavior among African-Americans: the minority melanoma paradox |
| Q27024061 | Melanoma: from mutations to medicine |
| Q28385292 | Meta-analysis of genome-wide association studies identifies multiple lung cancer susceptibility loci in never-smoking Asian women |
| Q35092291 | Modeling gene-environment interactions in malignant melanoma |
| Q35213835 | Molecular characterization of melanoma cases in Denmark suspected of genetic predisposition |
| Q38789271 | Molecular dermatopathology in malignant melanoma |
| Q37641784 | Molecular markers of tumor progression in melanoma |
| Q36984179 | Molecular targeted therapies in metastatic melanoma |
| Q54622331 | Neonatal UVB exposure accelerates melanoma growth and enhances distant metastases in Hgf-Cdk4(R24C) C57BL/6 mice. |
| Q34626994 | New founder germline mutations of CDKN2A in melanoma-prone families and multiple primary melanoma development in a patient receiving levodopa treatment. |
| Q44826012 | Novel germline CDKN2A mutation associated with head and neck squamous cell carcinomas and melanomas. |
| Q43610742 | Parental preferences for CDKN2A/p16 testing of minors |
| Q53808310 | Pediatric Predispositional Genetic Risk Communication: Potential Utility for Prevention and Control of Melanoma Risk as an Exemplar. |
| Q33638941 | Perceived risk following melanoma genetic testing: a 2-year prospective study distinguishing subjective estimates from recall |
| Q35574952 | Pharmacogenetic candidate genes for melanoma |
| Q47351477 | Phenocopies in melanoma-prone families with germ-line CDKN2A mutations. |
| Q36530303 | Pocket protein function in melanocyte homeostasis and neoplasia |
| Q33566677 | Population-based, case-control-family design to investigate genetic and environmental influences on melanoma risk: Australian Melanoma Family Study |
| Q39722414 | Predicting functional significance of cancer-associated p16(INK4a) mutations in CDKN2A. |
| Q50876678 | Predictors of psychological distress among individuals with a strong family history of malignant melanoma. |
| Q33370646 | Prevalence of variations in melanoma susceptibility genes among Slovenian melanoma families |
| Q35980965 | Progress in the epidemiological understanding of gene-environment interactions in major diseases: cancer |
| Q44959114 | Protective effect of copy number polymorphism of glutathione S-transferase T1 gene on melanoma risk in presence of CDKN2A mutations, MC1R variants and host-related phenotypes |
| Q38352887 | Radiotherapy for cutaneous melanoma: current and future applications |
| Q28394958 | Rare Germline Copy Number Variations and Disease Susceptibility in Familial Melanoma |
| Q50553409 | Red hair or not--reassessment of melanoma risk among CDKN2A carriers. |
| Q35173889 | Returning individual research results: development of a cancer genetics education and risk communication protocol |
| Q50169231 | Risks of melanoma and other cancers in melanoma-prone families over four decades. |
| Q30875021 | Role of key-regulator genes in melanoma susceptibility and pathogenesis among patients from South Italy |
| Q35840024 | Selection criteria for genetic assessment of patients with familial melanoma |
| Q34344031 | Skin cancer screening behaviours among individuals with a strong family history of malignant melanoma |
| Q37141819 | Sunlight ultraviolet irradiation and BRAF V600 mutagenesis in human melanoma. |
| Q33760876 | Sunscreen effects on UV-induced immune suppression |
| Q36334912 | Targeting the stromal fibroblasts: a novel approach to melanoma therapy |
| Q31131061 | Telomere length and the risk of cutaneous malignant melanoma in melanoma-prone families with and without CDKN2A mutations |
| Q59621927 | The common heat shock protein receptor CD91 is up-regulated on monocytes of advanced melanoma slow progressors |
| Q42439112 | The contribution of melanocortin 1 receptor gene polymorphisms and the agouti signalling protein gene 8818A>G polymorphism to cutaneous melanoma and basal cell carcinoma in a Polish population. |
| Q35190150 | The genetics of malignant melanoma: lessons from mouse and man. |
| Q56437102 | The genetics of melanoma |
| Q35910656 | The genetics of skin cancer. |
| Q36470928 | Timing and context: important considerations in the return of genetic results to research participants |
| Q47557700 | Truncating mutations of TP53AIP1 gene predispose to cutaneous melanoma. |
| Q35548058 | UVB-induced mutations in human key gatekeeper genes governing signalling pathways and consequences for skin tumourigenesis |
| Q35146567 | Ultraviolet radiation and cutaneous malignant melanoma |
| Q34401911 | Unaffected family members report improvements in daily routine sun protection 2 years following melanoma genetic testing |
| Q26778756 | Update in genetic susceptibility in melanoma |
| Q37710143 | Uptake of genetic counseling, genetic testing and surveillance in hereditary malignant melanoma (CDKN2A) in Norway |
| Q37187461 | Where genotype is not predictive of phenotype: towards an understanding of the molecular basis of reduced penetrance in human inherited disease |
| Q82637611 | [Genetic and epidemiological aspects of melanoma] |
| Q30877598 | eMelanoBase: an online locus-specific variant database for familial melanoma |
| Q36971412 | p16INK4a-induced senescence is disabled by melanoma-associated mutations |
Search more.